Literature DB >> 33498763

Neuropathological Changes in Nakalanga Syndrome-A Case Report.

An Hotterbeekx1,2, Martin Lammens3,4, Sylvester Onzivua5, Robert Lukande5, Francis Olwa6, Samir Kumar-Singh2,7, Stijn Van Hees1, Richard Idro8, Robert Colebunders1.   

Abstract

Nakalanga syndrome is a clinical manifestation of onchocerciasis-associated epilepsy characterized by stunting, delayed or absent secondary sexual development and skeletal deformities, and is often accompanied by epileptic seizures. The pathophysiology of Nakalanga syndrome is unknown. Here, we describe the post-mortem findings of a 17-year-old female who died with Nakalanga syndrome in northern Uganda. Macroscopic and histopathological examination of all major organs (liver, lungs, kidney and heart), including the brain and the pituitary gland, was performed. The suspected cause of death was malaria, and all major organs and pituitary gland appeared normal, except the lungs, which were edematous consistent with the malaria. Neuropathological changes include signs of neuro-inflammation (gliosis and activated microglia), which co-localized with tau-reactive neurofibrillary tangles and threads. The pathology was most abundant in the frontal cortex, thalamic and hypothalamic regions, and mesencephalon. The choroid plexus showed psammoma bodies. These findings indicate accelerated aging, probably due to repeated seizures. The neuropathological findings were similar to other persons who died with onchocerciasis-associated epilepsy. Examination of the pituitary gland did not reveal new information concerning the underlying pathophysiological mechanism of Nakalanga syndrome. Therefore, more post-mortem studies should be performed.

Entities:  

Keywords:  Nakalanga syndrome; Uganda; epilepsy; nodding syndrome; pituitary gland; post-mortem

Year:  2021        PMID: 33498763      PMCID: PMC7912209          DOI: 10.3390/pathogens10020116

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  17 in total

1.  Endocrine dysfunction in a Nakalanga dwarf.

Authors:  A J MARSHALL; J K CHERRY
Journal:  Trans R Soc Trop Med Hyg       Date:  1961-03       Impact factor: 2.184

2.  The Nakalanga syndrome in Kabarole District, Western Uganda.

Authors:  W Kipp; G Burnham; J Bamuhiiga; M Leichsenring
Journal:  Am J Trop Med Hyg       Date:  1996-01       Impact factor: 2.345

3.  Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan.

Authors:  J K Tumwine; K Vandemaele; S Chungong; M Richer; M Anker; Y Ayana; M L Opoka; D N Klaucke; A Quarello; P S Spencer
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

Review 4.  Psammomatous Cavernous Malformation Presenting as Drug-Resistant Epilepsy: Case Illustration and Review of Literature.

Authors:  Kanika Sharma; Piyush Kalakoti; John E Shaughnessy; Nestor De La Cruz; Rimal H Dossani; Peimin Zhu; Eduardo Gonzalez-Toledo; Christina Ledbetter; James B Pinskton; Anil Nanda; Rosario Maria Riel-Romero; Alireza Minagar; Christina Notarianni; Hai Sun
Journal:  World Neurosurg       Date:  2016-06-07       Impact factor: 2.104

5.  Clinical presentation of epilepsy in six villages in an onchocerciasis endemic area in Mahenge, Tanzania.

Authors:  Dan Bhwana; Bruno P Mmbando; Marieke Cj Dekker; Mohamed Mnacho; Advocatus Kakorozya; William Matuja; Williams H Makunde; Sarah Weckhuysen; Robert Colebunders
Journal:  Epileptic Disord       Date:  2019-10-01       Impact factor: 1.819

6.  Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy.

Authors:  Vikram Puvenna; Madeline Engeler; Manoj Banjara; Chanda Brennan; Peter Schreiber; Aaron Dadas; Ashkon Bahrami; Jesal Solanki; Anasua Bandyopadhyay; Jacqueline K Morris; Charles Bernick; Chaitali Ghosh; Edward Rapp; Jeffrey J Bazarian; Damir Janigro
Journal:  Brain Res       Date:  2015-11-07       Impact factor: 3.252

Review 7.  Nakalanga Syndrome: Clinical Characteristics, Potential Causes, and Its Relationship with Recently Described Nodding Syndrome.

Authors:  Kathrin Föger; Gina Gora-Stahlberg; James Sejvar; Emilio Ovuga; Louise Jilek-Aall; Erich Schmutzhard; Christoph Kaiser; Andrea S Winkler
Journal:  PLoS Negl Trop Dis       Date:  2017-02-09

8.  Nodding syndrome in Uganda is a tauopathy.

Authors:  Michael S Pollanen; Sylvester Onzivua; Janice Robertson; Paul M McKeever; Francis Olawa; David L Kitara; Amanda Fong
Journal:  Acta Neuropathol       Date:  2018-09-15       Impact factor: 17.088

9.  From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

Authors:  Robert Colebunders; Joseph Nelson Siewe Fodjo; Adrian Hopkins; An Hotterbeekx; Thomson L Lakwo; Akili Kalinga; Makoy Yibi Logora; Maria-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2019-07-18

10.  Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.

Authors:  Joseph Nelson Siewe Fodjo; Michel Mandro; Deby Mukendi; Floribert Tepage; Sonia Menon; Swabra Nakato; Françoise Nyisi; Germain Abhafule; Deogratias Wonya'rossi; Aimé Anyolito; Richard Lokonda; An Hotterbeekx; Robert Colebunders
Journal:  PLoS Negl Trop Dis       Date:  2019-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.